Avicularin alleviates acute liver failure by regulation of the TLR4 / MyD88 / NF‐κB and Nrf2/ HO ‐1/ GPX4 pathways to reduce inflammation and ferroptosis
Journal of Cellular and Molecular Medicine · 2023-11 · 27 (21) · 3326-3338
DOI: 10.1111/jcmm.17905 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 29.08.2023. Verfasst von Pei Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Ferroptosis, Liver Failure, Acute. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Acute liver failure (ALF) is an inflammation‐mediated hepatocyte death process associated with ferroptosis. Avicularin (AL), a Chinese herbal medicine, exerts anti‐inflammatory and antioxidative effects. However, the protective effect of AL and the mechanism on ALF have not been reported. Our in vivo results suggest that AL significantly alleviated lipopolysaccharide (LPS)/D‐galactosamine (D‐GalN)‐induced hepatic pathological injury, liver enzymes, inflammatory cytokines, reactive oxygen species and iron levels and increased the antioxidant enzyme activities (malondialdehyde and glutathione). Our further in vitro experiments demonstrated that AL suppressed inflammatory response in LPS‐stimulated RAW 264.7 cells via blocking the toll‐like receptor 4 (TLR4)/myeloid differentiation protein‐88 (MyD88)/nuclear factor kappa B (NF‐κB) pathway. Moreover, AL attenuated ferroptosis in D‐GalN‐induced HepG2 cells by activating the nuclear factor erythroid 2‐related factor 2 (Nrf2)/heme oxygenase 1 (HO‐1)/glutathione peroxidase 4 (GPX4) pathway. Therefore, AL can alleviate inflammatory response and ferroptosis in LPS/D‐GalN‐induced ALF, and its protective effects are associated with blocking TLR4/MyD88/NF‐κB pathway and activating Nrf2/HO‐1/GPX4 pathway. Moreover, AL is a promising therapeutic option for ALF and should be clinically explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang, China.
- Medical Innovation Center, The First Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Pei Shi, Songsong Yuan, Xiaoping Wu
Förderung
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Shi, P., Zhu, W., Fu, J., Liang, A., Zheng, T., Wen, Z., Wu, X., Peng, Y., Yuan, S., & Wu, X. (2023). Avicularin alleviates acute liver failure by regulation of the TLR4 / MyD88 / NF‐κB and Nrf2/ HO ‐1/ GPX4 pathways to reduce inflammation and ferroptosis. Journal of Cellular and Molecular Medicine, 27(21), 3326-3338. https://doi.org/10.1111/jcmm.17905
Vancouver
Shi P, Zhu W, Fu J, Liang A, Zheng T, Wen Z, et al. Avicularin alleviates acute liver failure by regulation of the TLR4 / MyD88 / NF‐κB and Nrf2/ HO ‐1/ GPX4 pathways to reduce inflammation and ferroptosis. Journal of Cellular and Molecular Medicine. 2023;27(21):3326-3338. doi:10.1111/jcmm.17905
BibTeX
@article{Shi2023,
author = {Shi, Pei and Zhu, Wentao and Fu, Jiwei and Liang, An and Zheng, Ting and Wen, Zhilong and Wu, Xincheng and Peng, Yuchen and Yuan, Songsong and Wu, Xiaoping},
title = {Avicularin alleviates acute liver failure by regulation of the TLR4 / MyD88 / NF‐κB and Nrf2/ HO ‐1/ GPX4 pathways to reduce inflammation and ferroptosis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
volume = {27},
number = {21},
pages = {3326--3338},
doi = {10.1111/jcmm.17905}
}
EUVIMED